L26/O-224 One-step warming of autologous vitrified oocytes versus fresh sibling and conventional warming: AI-based morphological assessment and clinical outcomes
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Cobo und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does a one-step warming (OSW) protocol affect oocyte viability and competence according to artificial intelligence (AI)-based image analysis and clinical outcomes? Summary answer An OSW protocol maintains oocyte competence and clinical outcomes comparable to conventional warming and is associated with higher survival and increased usable blastocyst likelihood. What is known already Recently, shortened warming protocols for vitrified oocytes have been developed to reduce the exposition to potentially toxic cryoprotectants and to optimize laboratory workflow efficiency. These protocols involve a 1-minute exposure to osmotic solution at 37 °C, avoiding the stepwise dilution of the cryoprotectants and minimizing the time oocytes remain exposed at non-physiological temperatures. To date, clinical studies have reported blastocyst development and pregnancy outcomes comparable to those achieved with conventional warming protocols. Artificial intelligence (AI) enables objective assessment of oocyte quality; however, its application to evaluate differences in post-warming viability and developmental competence across warming protocols remains unexplored. Study design, size, duration A total of 2,383 human oocytes from 202 ICSI cycles were included in the study. Three comparative assessments were performed either in combined (fresh + vitrified oocytes) or vitrified cycles as follows: (i) 42 combined cycles (239 fresh oocytes vs. 238 vitrified-OSW sibling oocytes); (ii) 59 combined cycles (389 fresh oocytes vs. 340 vitrified and conventionally warmed (CW) sibling oocytes); and (iii) 36 vitrified cycles (413 OSW oocytes) vs. 65 vitrified cycles (764 CW oocytes). Participants/materials, setting, methods AI-based Magenta software (Future Fertility, Canada) was applied to an image of each oocyte captured after ICSI, providing blastocyst likelihood score and euploidy probability. Clinical outcomes included survival, fertilization, usable blastocyst rate, and pregnancy outcome after transfer (n = 150). Mean oocyte ages were: 36.79±3.22 (combined cycles with OSW), 38.11±3.60 (combined cycles with CW), 40.74±3.84 (vitrified-OSW cycles), and 39.53±3.59 years (vitrified-CW cycles). Statistical analyses included ANOVA and logistic regression. Main results and the role of chance In combined cycles, post-warming survival rates were 95.0% in OSW oocytes and 89.1% in CW oocytes. Fresh oocytes had higher usable blastocyst rate (50.4% vs. 35.2%; p = 0.008) and Magenta score (5.58±2.86 vs. 4.85±2.64; p = 0.010) than vitrified-OSW sibling oocytes, while fertilization rate (74.9% vs. 73.0%; p = 0.671), clinical pregnancy (53.9% vs. 60.0%; p = 0.814), and AI-based euploidy probability were comparable between groups. Fertilization rate was higher in fresh than in vitrified-CW sibling oocytes (85.0% vs. 77.0%; p = 0.012). AI-based euploidy probability was slightly lower in fresh than in vitrified-CW oocytes (20.0% vs. 22.1%; p = 0.017), whereas usable blastocyst rate (42.7% vs. 40.8%; p = 0.668), clinical pregnancy (63.6% vs. 70.6%; p = 0.623), and Magenta score (5.49±2.73 vs. 5.16±2.70; p = 0.159) were similar. In vitrified-only cycles, post-warming survival was significantly higher in OSW than in CW oocytes (91.5% vs. 83.4%; p < 0.001). Fertilization rate (76.2% vs. 77.0%; p = 0.756), usable blastocyst rate (46.6% vs. 44.1%; p = 0.495), clinical pregnancy (52.6% vs. 63.5%; p = 0.395), Magenta score (5.74±2.85 vs. 5.86±3.02; p = 0.551), and AI-predicted euploidy probability (27.4% vs. 26.5%; p = 0.133) were comparable between groups. Logistic regression analysis identified the warming protocol as a predictor of usable blastocyst likelihood, which was increased in OSW compared with CW oocytes (OR = 1.515, 95% CI [1.086–2.113]; p = 0.014). Limitations, reasons for caution Clinical pregnancy outcomes were assessed in relatively small sample sizes, limiting statistical power for this endpoint. Wider implications of the findings Shortened warming represents a valid alternative to conventional warming without compromising oocyte competence. AI-based assessment provides objective support for protocol evaluation and may assist in optimizing cryopreservation strategies. Further studies are warranted to optimize warming protocols and validate their clinical impact. Trial registration number No
Zitieren
APA
Cobo, A., Conversa, L., Montanari, F., Murria, L., Vallejo, B., Sánchez-Chiva, E., Gámiz, P., & Alegre, L. (2026). L26/O-224 One-step warming of autologous vitrified oocytes versus fresh sibling and conventional warming: AI-based morphological assessment and clinical outcomes. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.222
Vancouver
Cobo A, Conversa L, Montanari F, Murria L, Vallejo B, Sánchez-Chiva E, et al. L26/O-224 One-step warming of autologous vitrified oocytes versus fresh sibling and conventional warming: AI-based morphological assessment and clinical outcomes. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.222
BibTeX
@article{Cobo2026,
author = {Cobo, A. and Conversa, L. and Montanari, F. and Murria, L. and Vallejo, B. and Sánchez-Chiva, E. and Gámiz, P. and Alegre, L.},
title = {L26/O-224 One-step warming of autologous vitrified oocytes versus fresh sibling and conventional warming: AI-based morphological assessment and clinical outcomes},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.222}
}
EUVIMED